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Background: Transfemoral venous access (TFV) is the cornerstone of minimally
invasive cardiac procedures. Although the presence of inferior vena cava filters
(IVCFs) was considered a relative contraindication to TFV procedures, small ex-
periences have suggested safety. We conducted a systematic review of the available
literature on cardiac procedural success of TFV with IVCF in‐situ.
Methods: Two independent reviewers searched PubMed, EMBASE, SCOPUS, and
Google Scholar from inception to October 2020 for studies that reported outcomes
in patients with IVCFs undergoing TFV for invasive cardiac procedures. We in-
vestigated a primary outcome of acute procedural success and reviewed the pooled
data for patient demographics, procedural complications, types of IVCF, IVCF dwell
time, and procedural specifics.
Results: Out of the 120 studies initially screened, 8 studies were used in the final
analysis with a total of 100 patients who underwent 110 procedures. The most
common IVCF was the Greenfield Filter (36%), 60% of patients were males and the
mean age was 67.8 years. The overall pooled incidence of acute procedural success
was 95.45% (95% confidence interval = 89.54–98.1) with no heterogeneity (I2 = 0%,
p = 1) and there were no reported filter‐related complications.
Conclusion: This systematic review is the largest study of its kind to demonstrate
the safety and feasibility of TFV access in a variety of cardiac procedures in the
presence of IVCF.
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1 | INTRODUCTION
Transfemoral venous access (TFV) is integral to invasive cardiovascular
procedures. Percutaneous balloon mitral valvuloplasty was one of the
earliest structural heart interventions employing trans‐venous access to
the left heart.1 Since then, many complex interventions utilizing TFV
access have been developed including leadless pacemaker implantation,
arrhythmia ablations, septal occluder device placement, transcatheter
valve‐in‐valve replacements, left atrial appendage occlusion, balloon
valvuloplasty, and mechanical circulatory support placement.
Abbreviations: DVT, deep vein thrombosis; IVCF, inferior vena cava filter; TFV, transfemoral venous access.
Kuldeep Shah and Sati Patel contributed equally and are co‐first authors.
Percutaneous inferior vena cava filters (IVCFs) are generally
indicated to prevent venous thromboembolism in those with deep
vein thrombosis (DVT) or pulmonary embolism (PE) who have con-
traindications to anticoagulation.2,3 Following the introduction of
percutaneous IVCFs in the 1970s, the annual implantation rate has
markedly increased in the United States with 13% of patients with
venous thromboembolism undergoing IVCF placement.4–8 IVCFs are
not without risk and can be complicated by device thrombosis, mi-
gration, embolization, perforation, and fracture.9–13 There are 17
types of filters available but only 53% are considered retrievable.14
In light of these complications and reports of guidewire entrapment,
the presence of IVCF has been considered a relative contraindication
for cardiovascular procedures requiring transfemoral approach.15,16
However, recent studies have demonstrated the safety and feasi-
bility of complex intracardiac procedures using TFV with catheter
passage through an IVCF.17–20 We sought to conduct a systemic
review of available cardiovascular literature in patients with IVCF
undergoing cardiovascular procedures. We have also proposed a
workflow on the management approach in patients with IVCF.
2 | METHODS
2.1 | Search strategy
The reporting of this systematic review was in compliance with
PRISMA (Preferred Reporting Items for Systematic Reviews and
Meta‐Analysis) guidelines.21 The initial search strategy was devel-
oped by two authors (Kuldeep Shah and Sati Patel). Systematic
search, using PubMed, EMBASE, SCOPUS, and Google Scholar from
inception to October 25, 2020, for studies that had reported out-
comes in patients with IVC filter that underwent TVA for invasive
procedures. We used the “AND” function to perform our literature
search (ivc filter) AND (femoral venous access), (ivc filter) AND
(ablation), (ivc filter) AND (left atrial appendage), (ivc filter) AND
(mitral valve), (ivc filter) AND (leadless pacemaker).
2.2 | Study selection and data extraction
The eligibility criteria for our systematic review included: (1) all
studies reporting data on TFV access in patients with IVCF and (2)
studies that included human subjects and published in the English
language. The references of all identified articles were also reviewed
for relevant studies meeting the eligibility criteria. Case reports,
editorials, or systematic reviews were excluded from our analysis.
Due to paucity of data, we decided to include case series with three
or more patients. Two investigators (Kuldeep Shah and Sati Patel)
independently performed the literature search and screened all titles
and full‐text versions of all relevant studies that met study inclusion
criteria. The data from included studies were extracted using a
standardized protocol and a data extraction form. Any discrepancies
between the two investigators were resolved with consultation with
the senior investigator (Nishaki Mehta). The following data from the
eligible studies were extracted: author name, study design, publica-
tion year, follow‐up duration, number of patients, number of proce-
dures, age, gender, duration of IVC filter, type of IVC filter, type of
procedure, number of sheaths, catheters and their sizes, type of
anticoagulation, success, and complications. The Newcastle Ottawa
Risk bias assessment tool was used to appraise the quality of in-
cluded studies.
2.3 | Outcomes
The primary efficacy outcome of our study was acute procedural
success (defined as ability to cross the IVC filter). In addition, we
reviewed the literature for causes of mortality, IVC thrombosis, and
procedural complications.
3 | STATISTICAL ANALYSIS
The meta‐analysis was performed using the meta package for R
version 4.0 and RStudio version 1.2 (R Core Team). For pooled
analysis, we used Logit method to establish variance of raw pro-
portions. Subsequently, we used DerSimonian–Laird random effect
model to combine the transformed proportions. Finally, we then back
transformed the pooled estimates using generalized mixed linear
models and plotted the data on the forest plot.22,23 Heterogeneity of
effect size among the included studies was assessed by Higgins
I‐squared (I2) statistic.24 We used the Wan method to estimate mean
and standard deviation when median with interquartile range was
reported.25
4 | RESULTS
4.1 | Search results and study characteristics
A total of 120 citations were identified during the initial search.
After a detailed evaluation, 112 records were excluded, and 8
studies were included in the final analysis (Figure 1). This meta‐
analysis of eight studies incorporated a total of 100 patients who
underwent 110 procedures.17–20,26–28 All studies included were
published between 2001 and 2020. The mean follow‐up period
was 7 months, 60% of patients were males, and the mean age was
67.8 years. The mean duration of IVCF dwell time was 24 months.
The type of filter was reported in seven studies with Greenfield
filter being the most common type (36%), though filter type was
unknown or not reported in 26% patients (Figure 2).29 The
number of sheaths or catheters traversing the IVC filter si-
multaneously ranged from 1 to 5 sheaths and/or catheters with
cumulative French size ranging from 6 to 33 Fr. The detailed
baseline characteristics of patients included in our study and the
quality of studies are highlighted in Tables 1 and S1.
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4.2 | Acute procedural success
The data for acute procedural success, defined as the ability to
successfully cross the IVCF was reported in all eight studies. The
overall pooled incidence of acute procedural success was 95.45%
(95% confidence interval [CI] = 89.54–98.1) with no heterogeneity
(I2 = 0%, p = 1; Figure 3). No study reported IVC filter‐related com-
plications including entrapment, filter migration, or damage to the
filter integrity. The IVCF was occluded in three patients undergoing
ventricular tachycardia (VT) ablations and in one patient undergoing
leadless pacemaker implantation.18,20 In all three patients under-
going VT ablation, TFV access was abandoned and a retrograde
arterial approach was used instead.18 In the patient undergoing
leadless pacemaker implantation, various wires and sheaths were
used in attempts to cross the occluded IVCF, however, these efforts
were unsuccessful and ultimately the procedure was aborted
altogether.20 In one patient undergoing leadless pacemaker im-
plantation, the IVCF was patent, however, there were multilevel
stenoses in the venous system requiring balloon angioplasty of the
right femoral vein, external iliac vein, and IVCF itself before the 27 Fr
introducer sheath could be safely introduced.20 No studies included
reported any instances of filter‐related complications including
entrapment/entanglement, filter migration, fracture, or embolic events.
Of all studies, Houmsse et al.20 reported three in‐hospital mortalities,
F IGURE 1 PRISMA flow diagram for studies
focusing on IVCF in invasive cardiology
procedures. IVCF, inferior vena cava filter;
PRISMA, Preferred Reporting Items for
Systematic Reviews and Meta‐analysis
F IGURE 2 Bar graph showing the number and different types of filters studied in the systematic review
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which were unrelated to the IVCF/EP procedure (septic shock,
endocarditis complication, and withdrawal of care for refractory HF).
5 | DISCUSSION
Through this systematic review, we demonstrate a high procedural
success rate (95%) using TFV access through IVCFs. To our knowl-
edge, this is the only systematic review assessing the outcome of
cardiac procedures in patients requiring TFV access with pre‐existing
IVCF. We determined a high procedural success rate (95%). How-
ever, patients with pre‐existing IVC thrombosis may pose procedural
challenge and should be evaluated. IVC thrombosis has been re-
ported to occur in all IVCFs, with a higher incidence in those with
retrievable filters, TrapEase (Cordis), and OptEase (Cordis) filters.30
Angel et al.10 in their systematic review found an overall 2.8%–8.8%
incidence of vena cava thrombosis or stenosis in patients with IVCFs,
with a higher incidence in those with Option Filters. We report a 4%
incidence of filter thrombosis in this systematic review consistent
with prior reports. All cases required the use of alternative access
sites or abandoning the procedure. When the TFV approach is not
feasible, cardiovascular procedures have been successfully per-
formed using alternative access sites.31–36 The transhepatic access
offers the inferior approach familiar to operators for these proce-
dures. However, the transhepatic approach carries a greater risk of
hematoma as it uses a noncompressible access site requiring vascular
plug or coil to achieve hemostasis. Additionally, the transhepatic
approach may favor anterior catheter angulation, making transseptal
puncture more challenging. Transhepatic access should therefore be
performed at experienced centers to reduce complications, which
may limit widespread applicability.32,35 Electrophysiology procedures
employing a superior approach via the superior vena cava have also
been reported.37–39 However, the superior approach carries a
greater risk of operator radiation exposure as positioning is closer to
the image intensifier. Further, catheter manipulation and contact can
be challenging from a superior approach owing to lack of familiarity
and equipment not designed for this route.38,39 Though alternative
procedural access sites can be considered in patients with IVCFs,
these carry their own risks and can be challenging to
perform.32,35,38–43
Several case reports and small case series have reported out-
comes of intracardiac procedures with IVCFs in situ. Kussmaul
et al.26 first reported the ability to perform transfemoral right heart
catheterizations across IVCFs in 10 patients with Greenfield (Boston
Scientific) IVCFs without complication.26 This success highlighted
that the presence of IVCFs does not serve as a strict contraindication
to the transfemoral approach. Soon after, many reported the safety
and feasibility of transfemoral structural heart interventions across
IVCFs including septal occluder device placement, transcatheter
percutaneous balloon mitral valvuloplasty, atrial septostomy, and
percutaneous mitral clip placement.27,28,44–46 Similarly, many EP
procedures have been successfully performed across a range of
IVCFs including percutaneous defibrillator lead extraction, cavo-
tricuspid isthmus ablations, leadless pacemaker implantation, and
pulmonary vein isolation.41,47–54 In each of these interventions, au-
thors advocate using direct fluoroscopic guidance when traversing
the IVCF and most used preprocedural CT scans or venograms to
ensure filter patency. Several procedural modifications have been
suggested to avoid IVCF complications. For example, preprocedural
CTs or venograms use of straight tipped or soft J‐tipped guide-
wires,26,44,51 first traversing the IVCF with the guidewire only to
ensure patency,18 and direct fluoroscopic guidance when traversing
the IVCF. Based on the aerial views of the filters, navigating
circumferentially versus centrally can offer more room for passage of
the sheaths. Utilizing multipurpose sheaths to redirect passage of the
wires might permit more leeway (Figure 4). Collectively, these
reports have supported the safety to navigate IVCFs during cardiac
procedures.
In our review, two high‐volume center studies accounted for
over 60% of the patients. These studies did not have routine pre‐
procedure testing or contrast venogram unless there was difficulty
crossing the wire. In such instances, contrast injection and serial
dilation were utilized. Attempted procedures through an IVCF with
either a partially or completely occluding thrombus may result in
iatrogenic PE. Since our systematic review has a limited number of
studies, we propose the following stepwise approach to all patients
F IGURE 3 Forest plot of incidence of acute safety with IVCFs. IVCF, inferior vena cava filter
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with IVCFs undergoing intracardiac procedures from a transfemoral
approach based on the limited literature review and an informal
survey of experienced cardiologists. Pre‐procedurally, the type of
filter (manufacturer, retrievable vs. non‐retrievable) and dwell time
should be ascertained as well as the indication to support the on-
going need for the filter. The IVCF should then be crossed first with a
guidewire with possible use of multipurpose sheaths under direct
fluoroscopic guidance followed by over the wire passage of neces-
sary equipment. In cases in which there is difficulty in crossing the
filter with a wire, contrast injection should be performed. In higher‐
risk patients, especially those at high risk of vena cava thrombosis‐
such as those with retrievable filters, those not on anticoagulation,
and in those with specific filter types that harbor higher rates of
thrombosis, a pre‐procedure CT venogram or after obtaining TVA,
contrast venography may be considered in advance of wire passage
F IGURE 4 Frontal and aerial views of three representative filters
(A, B: Vena‐Tech LGM filter; C, D: Simon nitinol filter; and E, F:
Greenfield filter) in the inferior vena cava (red outlines) and the blue
arrows indicate passage of the wire/sheath. As noted in the aerial
views, lateral or circumferential area for passage exceeds
central area
F IGURE 5 Proposed algorithm for managing a patient with IVCF who presents for invasive cardiology procedure requiring transfemoral
access. IVCF, inferior vena cava filter
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to ensure filter patency. Similarly, all procedural equipment should
be withdrawn under fluoroscopic guidance. At procedure completion,
IVCF positioning should be reviewed by fluoroscopy to ensure stable
filter positioning and integrity. If there is any concern, post‐
procedure venogram can be performed. Finally, the necessity for
ongoing IVCF should be addressed and patients should be referred
for retrieval if appropriate (Figure 5).
Due to the limited data on this topic, our systematic review is
confined by the small number of available studies. All studies in-
cluded in our pooled analysis were single‐arm, non‐randomized stu-
dies (three case series, three retrospective, and only two prospective
studies), two large studies contribute to 60% of the patients and
therefore subject to confounding factors. Additionally, the majority
of filters in the studies included were implanted for an average of
7 months (ranging from 1 month to 16 years), thus limiting applica-
tion to more recently placed filters.
6 | CONCLUSION
TVA is important to the success of a variety of invasive cardiac
procedures and IVCFs are not infrequently encountered. This sys-
tematic review and the current landscape of literature support the
safe and effective passage of equipment through a variety of IVCFs
for complex EP and structural heart cases. We have also proposed an
algorithmic approach for management based on our collative ex-
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